Deep brain stimulation boosts the strength of brain cell batteries
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
Drug for dyskinesia approved for phase 2 trials
A potential drug for dyskinesia has reached an important milestone and can now go forward into clinical trials.
Parkinson's UK and Sport England launch Parkinson's Power
Parkinson's UK has teamed up with Sport England to deliver an innovative project that will help inactive people with Parkinson's become and stay physically active.
Shaping the future of social care
An update on a parliamentary event to highlight the social care needs of working-age people with Parkinson's and other long term conditions.
GDNF clinical trial offers hope for restoring brain cells damaged in Parkinson’s
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
Prescription charges set to rise to £9
We update on the latest government announcement on the prescription charge rise and our campaigning.
Open publishing platform launched to share research results
Parkinson's UK is 1 of 24 members of the Association of Medical Research Charities that have worked in collaboration to develop and launch a new open publication platform – AMRC Open Research.
We condemn long waiting times for PIP tribunals
We gave oral evidence to the Work and Pensions Committee on their inquiry into the welfare safety net.
New trial to test if a probiotic drink could improve symptoms
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
Madopar availability update
The latest update on Madopar availability.